“…Increasing evidence has suggested that miRNAs may be used as potential diagnostic biomarkers for ICC and may also serve as therapeutic targets (19,20). miRNAs are able to stably exist in bodily fluids, including serum, plasma, saliva, urine and tears (20,21). Furthermore, miRNAs can be easily detected in small amounts and are resistant to degradation (20,22).…”